Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally
MarketWatch· Jaimy Lee· Aug 19, 2026 · 8:28 PM
The biopharmaceutical sector has struggled with a prolonged downturn in recent years but has been on an upswing of late.
This is a summary. Read the complete story at MarketWatch below.
Read full article at MarketWatchRelated Stories
marketsabout 4 hours ago
China posts weakest industrial profit growth this year, expanding 4.2% in August
Economists expect Beijing to lean harder on stimulus to stabilize corporate profitability, as consolidation accelerates in sectors facing sluggish demand and fierce competition.
CNBC Markets
marketsabout 10 hours ago
‘I want to make her proud’: My mother, a divorcée, died and I’m her executor. Do I need to file for probate?
“The only debts were utility and credit-card bills, which we will pay off.”
MarketWatch
marketsabout 18 hours ago
Micron could dethrone Nvidia and become the biggest driver of S&P 500 profit growth
Micron is increasingly important to the S&P 500, and its earnings report has become “a market event in and of itself.”
MarketWatch